The Pharmacy Benefit Managers (PBMs) marked up the cost of some prescription drugs by 1,000%, according to a report from the Federal Trade Commission (FTC). Some of the drugs with significant price jumps included those for HIV and cancer.
President Joe Biden released a farewell letter to the nation on Wednesday ahead of his Oval Office address. The letter reflected on his tenure, showcasing what he claims are key accomplishments and personal triumphs during his presidency.
He sat next to George Washington in the pew at St. Paul's Chapel in New York during the religious service following Washington's Presidential Inauguration.
He helped ratify the U.S. Constitution.
His...
As global challenges and crises continue to unfold, many Americans are taking proactive steps to ensure the safety and well-being of their families. While it is common to stockpile supplies like food, water, and emergency equipment, one essential item that is often overlooked is prescription medication.
At a recent press conference at Mar-a-Lago, President-elect Donald Trump made a bold promise to take on the powerful Pharmacy Benefit Managers (PBMs) responsible for inflating prescription drug prices in the U.S. Trump criticized PBMs, calling them a “horrible middleman” that profits by driving up drug costs without adding value. He vowed to eliminate the middleman and reduce drug prices to levels “that nobody has ever seen before.”
Healthcare spending in the United States surged by 7.5% to $4.9 trillion in 2023, driven by increased medical service use and rising enrollment in private health plans, according to a report from the Centers for Medicare and Medicaid Services (CMS).
House Speaker Mike Johnson (R-LA) is preparing to unveil a government spending bill that could include key components of President-elect Donald Trump’s healthcare agenda. Among the priorities under consideration is reforming Pharmacy Benefit Manager (PBM) practices, a move aimed at lowering prescription drug costs for seniors by tackling middleman-driven price inflation.
